Therapeutic Asset Ratings
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Risdiplam
Muscular Atrophy, Spinal
Scholar Rock, Inc.
P4
A
(80)
Rizatriptan
Migraine
Antonios Likourezos
P4
A
(80)
Tezacaftor
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated
P4
A
(80)
Lanadelumab
Hereditary Angioedema (HAE)
Takeda
P3
A
(80)
Nonacog Beta Pegol
Haemophilia B
Novo Nordisk A/S
P3
A
(80)
Pegunigalsidase Alfa
Fabry Disease
Chiesi Italia
P3
A
(80)
VINCRISTINE SULFATE
Contiguous Stage II Adult Diffuse Large Cell Lymphoma
National Cancer Institute (NCI)
P2/3
A
(80)
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Cerebral Infarction
Asan Medical Center
P4
BBB
(79)
Acetylsalicylic Acid
Coronary Artery Disease
Rajaie Cardiovascular Medical and Research Center
P4
BBB
(79)
Acp-103
Parkinson's Disease Psychosis
Tasly Pharmaceutical Group Co., Ltd
P4
BBB
(79)
Apixaban
Venous Thromboembolism
Regeneron Pharmaceuticals
P4
BBB
(79)
Apixaban
Venous Thrombosis
Northern Jiangsu People's Hospital
P4
BBB
(79)
Arsenic Trioxide
Acute Promyelocytic Leukemia
Quetzal Therapeutics
P4
BBB
(79)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Infantile Spasms
University of California, Los Angeles
P4
BBB
(79)
Cyclophosphamide
Adult Acute Lymphoblastic Leukemia in Remission
The First Affiliated Hospital of Zhengzhou University
P4
BBB
(79)
Cytosin-Arabinosid
Adult Acute Lymphocytic Leukemia
PETHEMA Foundation
P4
BBB
(79)
Dabigatran
Atrial Fibrillation
Pfizer
P4
BBB
(79)
Deferasirox
Beta-thalassemia Major
Pakistan Blood and Marrow Transplant (PBMT) Group
P4
BBB
(79)
Denosumab
Bone Metastases
Kelly Fitzgerald, MD
P4
BBB
(79)
DEXAMETHASONE
Adult Acute Lymphocytic Leukemia
Shanxi Bethune Hospital
P4
BBB
(79)
ds-5565
Diabetic Peripheral Neuropathic Pain
Bangladesh Medical University
P4
BBB
(79)
Eptinezumab
Migraine
Stanford University
P4
BBB
(79)
Ezetimibe
Hypercholesterolemia
Punjab Institute of Cardology
P4
BBB
(79)
FLUOROURACILUM
Unresectable or Metastatic Colorectal Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd.
P4
BBB
(79)
Glatiramer
Relapsing Remitting Multiple Sclerosis
University Hospital, Montpellier
P4
BBB
(79)
Showing 76 to 100 of 63,772 assets
Previous
Page 4 of 2551
Next